The impact of histology and ground-glass opacity component on volume doubling time in primary lung cancer

被引:39
|
作者
Obayashi, Kai [1 ,2 ]
Shimizu, Kimihiro [1 ,2 ]
Nakazawa, Seshiru [1 ,2 ]
Nagashima, Toshiteru [3 ]
Yajima, Toshiki [1 ,2 ]
Kosaka, Takayuki [1 ,2 ]
Atsumi, Jun [1 ,2 ]
Kawatani, Natsuko [1 ,2 ]
Yazawa, Tomohiro [4 ]
Kaira, Kyoichi [5 ]
Mogi, Akira [1 ,2 ]
Kuwano, Hiroyuki [1 ,2 ]
机构
[1] Gunma Univ Hosp, Div Gen Thorac Surg, Integrat Ctr Gen Surg, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan
[2] Gunma Univ, Dept Gen Surg Sci, Grad Sch Med, Maebashi, Gunma, Japan
[3] Natl Hosp Org Shibukawa Med Ctr, Dept Gen Thorac Surg, Shibukawa, Gunma, Japan
[4] Natl Hosp Org Takasaki Gen Med Ctr, Dept Gen Thorac Surg, Takasaki, Gunma, Japan
[5] Gunma Univ, Grad Sch Med, Dept Oncol Clin Dev, Maebashi, Gunma, Japan
基金
日本学术振兴会;
关键词
Volume doubling time (VDT); ground glass opacity (GGO); primary lung cancer (PLC); adenocarcinoma; TUMOR-GROWTH; CLASSIFICATION; ADENOCARCINOMA; SURVIVAL;
D O I
10.21037/jtd.2018.08.118
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Correlations between volume doubling time (VDT) of primary lung cancer (PLC), histology, and ground glass opacity (GGO) components remain unclear. The purpose of this study was to evaluate and compare VDT of PLC in terms of histology and presence or absence of GGO components. Methods: A total of 371 surgically resected PLCs from 2003 to 2015 in our institute were retrospectively reviewed. The VDT was calculated both from the diameters of the entire tumor and of consolidation by using the approximation formula of Schwartz. Results: The median VDTs of adenocarcinoma, squamous cell carcinoma, and others (large cell neuroendocrine carcinomas, small cell lung carcinomas, pulmonary pleomorphic carcinomas, and large cell carcinomas combined) were 261, 70, and 70 days, respectively; these differ significantly (P<0.001). All PLCs with GGO were adenocarcinomas. The VDT of adenocarcinomas with GGO was significantly longer than that of those without GGO (median VDT: 725 and 177 days, respectively), squamous cell carcinomas, and others. When the VDT calculated from the maximum diameter of consolidation component was compared, adenocarcinomas with GGO also showed significantly slower growth than those without GGO (median VDT: 248 versus 177 days, respectively, P=0.040). Conclusions: The VDT of PLCs is longest for adenocarcinomas. VDT was significantly longer in adenocarcinomas with GGO components than in those without such components, irrespective of VDT calculated on the basis of either the entire tumor diameter or consolidation diameter.
引用
收藏
页码:5428 / +
页数:8
相关论文
共 50 条
  • [41] Ground-glass opacity showed response to immunotherapy in cancer patients.
    Wu, Fang
    Hu, Chunhong
    Liu, Xiaohan
    Li, Yizheng
    Zeng, Yue
    He, Liuer
    Liu, Junqi
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [42] What do we know about ground-glass opacity nodules in the lung?
    Lee, Choon-Taek
    TRANSLATIONAL LUNG CANCER RESEARCH, 2015, 4 (05) : 656 - 659
  • [43] Pure Ground-Glass Opacity Neoplastic Lung Nodules: Histopathology, Imaging, and Management
    Lee, Ho Yun
    Choi, Yoon-La
    Lee, Kyung Soo
    Han, Joungho
    Zo, Jae Ill
    Shim, Young Mog
    Moon, Jung Won
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2014, 202 (03) : W224 - W233
  • [44] Ground-glass opacity-featured lung adenocarcinoma has no response to chemotherapy
    Zhang, Yang
    Deng, Chaoqiang
    Ma, Xiao
    Gao, Zhendong
    Wang, Shengping
    Zheng, Qiang
    Xia, Guozhan
    Wen, Zhexu
    Han, Han
    Fu, Fangqiu
    Liu, Quan
    Hu, Hong
    Li, Yuan
    Wong, Kwok-Kin
    Chen, Haiquan
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (09) : 2411 - 2417
  • [45] Ground-Glass Opacity Is a Strong Prognosticator for Pathologic Stage IA Lung Adenocarcinoma
    Miyoshi, Tomohiro
    Aokage, Keiju
    Katsumata, Shinya
    Tane, Kenta
    Ishii, Genichiro
    Tsuboi, Masahiro
    ANNALS OF THORACIC SURGERY, 2019, 108 (01): : 249 - 255
  • [46] How Long Should Small Lung Lesions of Ground-Glass Opacity be Followed?
    Kobayashi, Yoshihisa
    Fukui, Takayuki
    Ito, Simon
    Usami, Noriyasu
    Hatooka, Shunzo
    Yatabe, Yasushi
    Mitsudomi, Tetsuya
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (03) : 309 - 314
  • [47] Histopathologic Results of Surgically Resected Pure Ground-Glass Opacity Lung Nodules
    Lee, Geun Dong
    Park, Chul Hwan
    Do, Young Woo
    Lee, Sungsoo
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S636 - S637
  • [48] Ground-glass opacity-featured lung adenocarcinoma has no response to chemotherapy
    Yang Zhang
    Chaoqiang Deng
    Xiao Ma
    Zhendong Gao
    Shengping Wang
    Qiang Zheng
    Guozhan Xia
    Zhexu Wen
    Han Han
    Fangqiu Fu
    Quan Liu
    Hong Hu
    Yuan Li
    Kwok-Kin Wong
    Haiquan Chen
    Journal of Cancer Research and Clinical Oncology, 2020, 146 : 2411 - 2417
  • [49] Integrative Omics Analysis Reveals Metabolic Features of Ground-Glass Opacity-Associated Lung Cancer
    Shi, Shuai
    Luo, Dayuan
    Yang, Yanyi
    Wang, Xiang
    JOURNAL OF CANCER, 2024, 15 (07): : 1848 - 1862
  • [50] A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer
    Suzuki, Kenji
    Watanabe, Shun-ichi
    Wakabayashi, Masashi
    Saji, Hisashi
    Aokage, Keiju
    Moriya, Yasumitsu
    Yoshino, Ichiro
    Tsuboi, Masahiro
    Nakamura, Shinichiro
    Nakamura, Kenichi
    Mitsudomi, Tetsuya
    Asamura, Hisao
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2022, 163 (01): : 289 - +